136 related articles for article (PubMed ID: 10093689)
1. Breast cancer screening by mammography in Norway. Is it cost-effective?
Norum J
Ann Oncol; 1999 Feb; 10(2):197-203. PubMed ID: 10093689
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.
Bryan S; Brown J; Warren R
J Epidemiol Community Health; 1995 Feb; 49(1):70-8. PubMed ID: 7707010
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the Norwegian breast cancer screening program.
van Luijt PA; Heijnsdijk EA; de Koning HJ
Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
[TBL] [Abstract][Full Text] [Related]
4. Prevention of colorectal cancer: a cost-effectiveness approach to a screening model employing sigmoidoscopy.
Norum J
Ann Oncol; 1998 Jun; 9(6):613-8. PubMed ID: 9681074
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness of mammography screening in Norway].
Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.
Szeto KL; Devlin NJ
Health Policy; 1996 Nov; 38(2):101-15. PubMed ID: 10160378
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
9. Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening.
Wang H; Kåresen R; Hervik A; Thoresen SO
Cancer Causes Control; 2001 Jan; 12(1):39-45. PubMed ID: 11227924
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
11. [Health economics analysis of breast cancer screening].
Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992.
Leivo T; Sintonen H; Tuominen R; Hakama M; Pukkala E; Heinonen OP
Cancer; 1999 Aug; 86(4):638-46. PubMed ID: 10440691
[TBL] [Abstract][Full Text] [Related]
13. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness.
Rosenquist CJ; Lindfors KK
Radiology; 1994 Jun; 191(3):647-50. PubMed ID: 8184041
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
[TBL] [Abstract][Full Text] [Related]
15. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
Menon A; Devlin NJ; Richardson AK
N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.
Schousboe JT; Sprague BL; Abraham L; O'Meara ES; Onega T; Advani S; Henderson LM; Wernli KJ; Zhang D; Miglioretti DL; Braithwaite D; Kerlikowske K
Ann Intern Med; 2022 Jan; 175(1):11-19. PubMed ID: 34807717
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
18. [Cost-benefit analysis of a mammography screening program extended to all the national territory].
Vanara F; Zappa M; Rosselli del Turco M; Segnan N; Paci E; Ponti A
Epidemiol Prev; 1997; 21(2):118-28. PubMed ID: 9378179
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
